Abstract
Objective
This study investigated the association between green tea consumption and leukemia.
Methods
A total of 252 cases (90.3% response) and 637 controls (53.4% response) were enrolled. Controls were matched for cases on age and gender. Information was collected on participants’ living habits, including tea consumption. Green tea was used as a standard to estimate the total amount of individual catechin consumption. We stratified individual consumption of catechins into four levels. Conditional logistic regression models were fit to subjects aged 0–15 and 16–29 years to evaluate separate associations between leukemia and catechin consumption.
Results
A significant inverse association between green tea consumption and leukemia risk was found in individuals aged 16–29 years, whereas no significant association was found in the younger age groups. For the older group with higher amounts of tea consumption (>550 units of catechins), the adjusted odds ratio (OR) compared with the group without tea consumption was 0.47 [95% confidence interval (CI) = 0.23–0.97]. After we adjusted for smoking status and medical irradiation exposure, the overall OR for all participants was 0.49 (95% CI = 0.27–0.91), indicating an inverse relation between large amounts of catechins and leukemia.
Conclusion
Drinking sufficient amounts of tea, especially green tea, which contains more catechins than oolong tea and black tea, may reduce the risk of leukemia.
Similar content being viewed by others
References
Kada T, Kaneko K, Matsuzaki S, Matsuzaki T, Hara Y (1985) Detection and chemical identification of natural bio-antimutagens. A case of the green tea factor. Mutat Res 150(1–2):127–132. doi:10.1016/0027-5107(85)90109-5
Mukhtar H, Ahmad N (1999) Green tea in chemoprevention of cancer. Toxicol Sci 52(2 Suppl):111–117. doi:10.1093/toxsci/52.2.111
Spinella F, Rosano L, Di Castro V et al (2006) Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol Cancer Ther 5(6):1483–1492. doi:10.1158/1535-7163.MCT-06-0053
Zhang Q, Tang X, Lu Q, Zhang Z, Rao J, Le AD (2006) Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther 5(5):1227–1238. doi:10.1158/1535-7163.MCT-05-0490
Mukhtar H (1994) Cancer chemoprevention by green tea components. Adv Exp Med Biol 354:123–134
Tsugane S, Sasazuki S (2007) Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10(2):75–83. doi:10.1007/s10120-007-0420-0
Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB (2007) Diet and breast cancer: a review of the prospective observational studies. Cancer 109(12):2712–2749. doi:10.1002/cncr.22654
Jian L, Lee AH, Binns CW (2007) Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr 16(1):453–457
Wang JM, Xu B, Rao JY, Shen HB, Xue HC, Jiang QW (2007) Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol 19(2):171–176. doi:10.1097/MEG.0b013e32800ff77a
Kuriyama S, Shimazu T, Ohmori K et al (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296(10):1255–1265. doi:10.1001/jama.296.10.1255
Sun CL, Yuan JM, Koh WP, Yu MC (2006) Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 27(7):1301–1309. doi:10.1093/carcin/bgl024
Zhang XH, Andreotti G, Gao YT et al (2006) Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case–control study in Shanghai, China. Int J Cancer 118(12):3089–3094. doi:10.1002/ijc.21748
Larsson SC, Wolk A (2005) Tea consumption and ovarian cancer risk in a population-based cohort. Arch Intern Med 165(22):2683–2686. doi:10.1001/archinte.165.22.2683
Linet MS (1996) Leukemias. In: Harras A (ed) Cancer rates and risks, 4th edn. National Cancer Institute, Bethesda, MD
Linet MS, Cartwright RA (1996) The leukemias. Oxford University Press, New York, NY
Miller R et al (1996) Childhood. In: Harras A (ed) Cancer rates and risks, 4th edn. National Cancer Institute, Bethesda, MD
Yu CL, Wang SF, Pan PC et al (2006) Residential exposure to petrochemicals and the risk of leukemia: using geographic information system tools to estimate individual-level residential exposure. Am J Epidemiol 164(3):200–207. doi:10.1093/aje/kwj182
Zahm SH, Ward M (1998) Pesticides and childhood cancer. Environ Health Perspect 106(3):893–908. doi:10.2307/3434207
Dreosti IE (1996) Bioactive ingredients: antioxidants and polyphenols in tea. Nutr Rev 54:S51–S58
Geetha T, Garg A, Chopra K, Pal Kaur I (2004) Delineation of antimutagenic activity of catechin, epicatechin and green tea extract. Mutat Res 556:65–74. doi:10.1016/j.mrfmmm.2004.07.003
Weisburger JH, Hara Y, Dolan L, Luo FO, Pittman B, Zang E (1996) Tea polyphenols as inhibitors of mutagenicity of major classes of carcinogens. Mutat Res 371:57–63. doi:10.1016/S0165-1218(96)90094-4
Yen GC, Chen HY (1996) Relationship between antimutagenic activity and major components of various teas. Mutagenesis 11:37–41. doi:10.1093/mutage/11.1.37
Nakazato T, Ito K, Ikeda Y, Kizaki M (2005) Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clin Cancer Res 11:6040–6049. doi:10.1158/1078-0432.CCR-04-2273
Béliveau R, Gingras D (2004) Green tea: prevention and treatment of cancer by nutraceuticals. Lancet 364(9439):1021–1022. doi:10.1016/S0140-6736(04)17076-1
Hamblin T (2006) Natural products and the treatment of leukemia. Leuk Res 30:649–650. doi:10.1016/j.leukres.2005.10.023
Smith DM, Dou OP (2001) Green tea polyphenol epigallocatechin inhibits DNA replication and consequently induces leukemia cell apoptosis. Int J Mol Med 7(6):645–652
Li YL, Moysich KB, Baer MR et al (2006) Intakes of selected food groups and beverages and adult acute myeloid leukemia. Leuk Res 30(12):1507–1515. doi:10.1016/j.leukres.2006.03.017
Bushman JL (1998) Green tea and cancer in humans: a review of the literature. Nutr Cancer 31:151–159
Annabi B, Currie JC, Moghrabi A, Beliveau R (2006) Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg. Leuk Res 31(9):1277–1284
Komori A, Yatsunami J, Okabe S et al (1993) Anticarcinogenic activity of green tea polyphenols. Jpn J Clin Oncolo 23:186–190
Morre DJ, Bridge A, Wu L-Y, Morre DM (2000) Epigallocatechin gallate inhibits preferentiallythe NADH oxidase and growth of transformed cells in culture. Biochem Pharmacol 60:937–946. doi:10.1016/S0006-2952(00)00426-3
Ng KK, Miller VA, Grant SC et al. (1999) Phase I and clinical pharmacologic study of green tea extract (GTE) in patients with advanced solid tumors (ASCO). Am Soc Clinical Oncology Meeting abstract #853
Rothman KJ, Green IS (1998) Modern epidemiology. Lippincott-Raven, Philadelphia, PA
Kuroda Y, Hara Y (1999) Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res 436(1):69–97. doi:10.1016/S1383-5742(98)00019-2
Acknowledgments
The authors gratefully acknowledge Chien-Chin Chou for questionnaire data verification, Janna Frelich for data management, and Thomas J., Yuhao Chen, and Lia Shimada for technical assistance. The study was funded by National Institutes of Health (ES09723, ES00002). The members of the Kaohsiung Leukemia Research Group were as follows: Kaohsiung Medical University Chung-Ho Memorial Hospital—Tai-Tsung Chang, Sheng-Fung Lin, Shyh-Shin Chiou, Ren-Chin Jang, Hui-Hua Hsiao, Ta-Chih Liu, and Pei-Chin Lin; Kaohsiung Chang Gung Memorial Hospital—Chih-Cheng Hsiao, Jiunn-Ming Sheen, Ching-Yuan Kuo, Ming-Chung Wang, Cheng-Hua Huang, and Chung-Bin Huang; and Kaohsiung Veterans General Hospital—Shyh-Jer Lin, Yu-Ming Sun, Kai-Sheng Hsieh, and Yu-Hsiang Chang; and Shaw Chwan Memorial Hospital—Yuk-Cheung Wong; and E-Da Hospital—Hung-Bo Wu.
Funding
National Institutes of Health (ES09723, ES00002).
Conflict of interest
None declared.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Kuo, YC., Yu, CL., Liu, CY. et al. A population-based, case–control study of green tea consumption and leukemia risk in southwestern Taiwan. Cancer Causes Control 20, 57–65 (2009). https://doi.org/10.1007/s10552-008-9217-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-008-9217-7